Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001622964-17-000001
Filing Date
2017-06-28
Accepted
2017-06-28 12:27:48
Documents
1
Effectiveness Date
2017-06-28
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9749
  Complete submission text file 0001622964-17-000001.txt   10816
Mailing Address 257 PARK AVENUE SOUTH 15TH FLOOR NEW YORK NY 10010
Business Address 257 PARK AVENUE SOUTH 15TH FLOOR NEW YORK NY 10010 212-498-0011 EXT 301
Syntimmune, Inc. (Filer) CIK: 0001622964 (see all company filings)

EIN.: 464167490 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-289606 | Film No.: 17934504